Rigel Pharma (RIGL) Misses Q1 EPS by 4c
Tweet Send to a FriendGet Alerts RIGL Hot Sheet
Price: $4.52 -1.31%
Revenue Growth %: -100.0%
Financial Fact:
Interest income: 136K
Today's EPS Names:
MGT, RXN, KID, More
Revenue Growth %: -100.0%
Financial Fact:
Interest income: 136K
Today's EPS Names:
MGT, RXN, KID, More
Trade RIGL Now!
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) reported Q1 EPS of ($0.40), $0.04 worse than the analyst estimate of ($0.36).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Best Buy (BBY) Posts Q1 adj.-EPS of 32c; Comps Down 1.1%
- Qihoo 360 Technology (QIHU) Reports In-Line Q1 EPS; Guides Q2 Sales
- Medtronic, Inc. (MDT) Tops Q4 EPS by 7c; Guides FY14
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
